Myotonia, Potassium-Aggravated (MYOSCN4A)

Alias:

Potassium-Aggravated Myotonia

Myotonia Fluctuans

Myotonia Congenita, Atypical, Acetazolamide-Responsive

Myotonia Permanens

Pam

Acetazolamide-Responsive Myotonia

Sodium Channel Muscle Disease

Potassium Aggravated Myotonia

K+-Aggravated Myotonia

K-Aggravated Myotonia

Myotonia Congenita, Acetazolamide-Responsive

Acetazolamide-Responsive Congenital Myotonia

Myotonia Congenita Acetazolamide-Responsive

Exercise-Induced Delayed-Onset Myotonia

Myotonia-Painful Contractions Syndrome

Acz-Responsive Congenital Myotonia

Hyperkalemic Periodic Paralysis

Myotonia Potassium-Aggravated

Myotonia Congenita, Atypical

Painful Congenital Myotonia

Myotonia Congenita Atypical

Sodium Channel Myotonia

Acz-Responsive Myotonia

Myotonia Scn4a-Related

Fluctuating Myotonia

Painful Myotonia

Myoscn4a

Scm

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Myotonia, Potassium-Aggravated, also known as potassium-aggravated myotonia, is related to myotonia and paramyotonia congenita, and has symptoms including stridor, muscular stiffness and myalgia. An important gene associated with Myotonia, Potassium-Aggravated is SCN4A (Sodium Voltage-Gated Channel Alpha Subunit 4). The drugs Diclofenamide and Lamotrigine have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle and brain, and related phenotypes are hypertonia and myotonia

Related ID：

MALACARDS：MYT030

OMIM：608390

MESH：D020967